202 related articles for article (PubMed ID: 8062949)
1. Ovulation induction with gonadotropins and intrauterine insemination compared with in vitro fertilization and no therapy: a prospective, nonrandomized, cohort study and meta-analysis.
Peterson CM; Hatasaka HH; Jones KP; Poulson AM; Carrell DT; Urry RL
Fertil Steril; 1994 Sep; 62(3):535-44. PubMed ID: 8062949
[TBL] [Abstract][Full Text] [Related]
2. In vitro fertilisation for unexplained subfertility.
Pandian Z; Bhattacharya S; Vale L; Templeton A
Cochrane Database Syst Rev; 2005 Apr; (2):CD003357. PubMed ID: 15846658
[TBL] [Abstract][Full Text] [Related]
3. Tubal catheterization for intrafallopian insemination and transvaginal gamete (GIFT) or zygote intrafallopian transfer (ZIFT): our experience in a total of 1128 treatment cycles.
Tzafettas J; Loufopoulos A; Stephanatos A; Mukherjee A
J Assist Reprod Genet; 1994 Jul; 11(6):283-8. PubMed ID: 7734912
[TBL] [Abstract][Full Text] [Related]
4. Gamete intra-fallopian transfer or intrauterine insemination after controlled ovarian hyperstimulation for treatment of infertility due to endometriosis.
Lodhi S; Abdel Fattah A; Abozaid T; Murphy J; Formantini E; Sasy M; Barber K; Abuzeid M
Gynecol Endocrinol; 2004 Sep; 19(3):152-9. PubMed ID: 15697077
[TBL] [Abstract][Full Text] [Related]
5. In vitro fertilisation for unexplained subfertility.
Pandian Z; Bhattacharya S; Nikolaou D; Vale L; Templeton A
Cochrane Database Syst Rev; 2002; (2):CD003357. PubMed ID: 12076476
[TBL] [Abstract][Full Text] [Related]
6. Is IVF-served two different ways-more cost-effective than IUI with controlled ovarian hyperstimulation?
Tjon-Kon-Fat RI; Bensdorp AJ; Bossuyt PM; Koks C; Oosterhuis GJ; Hoek A; Hompes P; Broekmans FJ; Verhoeve HR; de Bruin JP; van Golde R; Repping S; Cohlen BJ; Lambers MD; van Bommel PF; Slappendel E; Perquin D; Smeenk J; Pelinck MJ; Gianotten J; Hoozemans DA; Maas JW; Groen H; Eijkemans MJ; van der Veen F; Mol BW; van Wely M
Hum Reprod; 2015 Oct; 30(10):2331-9. PubMed ID: 26269539
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of treatment for unexplained infertility.
Guzick DS; Sullivan MW; Adamson GD; Cedars MI; Falk RJ; Peterson EP; Steinkampf MP
Fertil Steril; 1998 Aug; 70(2):207-13. PubMed ID: 9696208
[TBL] [Abstract][Full Text] [Related]
8. Superovulation with intrauterine insemination in the treatment of infertility: a possible alternative to gamete intrafallopian transfer and in vitro fertilization.
Dodson WC; Whitesides DB; Hughes CL; Easley HA; Haney AF
Fertil Steril; 1987 Sep; 48(3):441-5. PubMed ID: 3114010
[TBL] [Abstract][Full Text] [Related]
9. A prospective controlled study of in-vitro fertilization, gamete intra-fallopian transfer and intrauterine insemination combined with superovulation.
Mills MS; Eddowes HA; Cahill DJ; Fahy UM; Abuzeid MI; McDermott A; Hull MG
Hum Reprod; 1992 Apr; 7(4):490-4. PubMed ID: 1522191
[TBL] [Abstract][Full Text] [Related]
10. Gamete intra-Fallopian transfer or in-vitro fertilization after failed ovarian stimulation and intrauterine insemination in unexplained infertility?
Ranieri M; Beckett VA; Marchant S; Kinis A; Serhal P
Hum Reprod; 1995 Aug; 10(8):2023-6. PubMed ID: 8567835
[TBL] [Abstract][Full Text] [Related]
11. Transcervical gamete and zygote intrafallopian transfer. Does it enhance pregnancy rates in an assisted reproduction program?
Hurst BS; Tucker KE; Guadagnoli S; Awoniyi CA; Schlaff WD
J Reprod Med; 1996 Nov; 41(11):867-70. PubMed ID: 8951140
[TBL] [Abstract][Full Text] [Related]
12. The pregnancy rates with intrauterine insemination (IUI) in superovulated cycles employing different protocols (clomiphen citrate (CC), human menopausal gonadotropin (HMG) and HMG+CC) and in natural ovulatory cycle.
Mahani IM; Afnan M
J Pak Med Assoc; 2004 Oct; 54(10):503-5. PubMed ID: 15552282
[TBL] [Abstract][Full Text] [Related]
13. Cycle-specific and cumulative fecundity in patients with endometriosis who are undergoing controlled ovarian hyperstimulation-intrauterine insemination or in vitro fertilization-embryo transfer.
Dmowski WP; Pry M; Ding J; Rana N
Fertil Steril; 2002 Oct; 78(4):750-6. PubMed ID: 12372451
[TBL] [Abstract][Full Text] [Related]
14. In vitro fertilisation and gamete intrafallopian transfer: an integrative analysis of research, 1987-1992.
Kenny DT
Br J Obstet Gynaecol; 1995 Apr; 102(4):317-25. PubMed ID: 7612516
[TBL] [Abstract][Full Text] [Related]
15. Obstetric implications for and identification of women with a normal clomiphene citrate challenge test result who have a poor response to gonadotropins.
Hofmann GE; Sosnowski J; Khoury J; Kearns L; Thie J
Fertil Steril; 2004 Oct; 82(4):908-12. PubMed ID: 15482767
[TBL] [Abstract][Full Text] [Related]
16. Fertility treatment in the forty and older woman.
Auyeung A; Klein ME; Ratts VS; Odem RR; Williams DB
J Assist Reprod Genet; 2001 Dec; 18(12):638-43. PubMed ID: 11808844
[TBL] [Abstract][Full Text] [Related]
17. Gonadotrophins versus clomiphene citrate with or without IUI in women with normogonadotropic anovulation and clomiphene failure: a cost-effectiveness analysis.
Bordewijk EM; Weiss NS; Nahuis MJ; Bayram N; van Hooff MHA; Boks DES; Perquin DAM; Janssen CAH; van Golde RJT; Lambalk CB; Goddijn M; Hompes PG; van der Veen F; Mol BWJ; van Wely M;
Hum Reprod; 2019 Feb; 34(2):276-284. PubMed ID: 30576539
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of primary offer of IVF vs. primary offer of IUI followed by IVF (for IUI failures) in couples with unexplained or mild male factor subfertility.
Pashayan N; Lyratzopoulos G; Mathur R
BMC Health Serv Res; 2006 Jun; 6():80. PubMed ID: 16796733
[TBL] [Abstract][Full Text] [Related]
19. A comparative analysis of the cycle fecundity rates associated with combined human menopausal gonadotropin (hMG) and intrauterine insemination (IUI) versus either hMG or IUI alone.
Chaffkin LM; Nulsen JC; Luciano AA; Metzger DA
Fertil Steril; 1991 Feb; 55(2):252-7. PubMed ID: 1899392
[TBL] [Abstract][Full Text] [Related]
20. The association between endometrial thickness and pregnancy outcome in gonadotropin-stimulated intrauterine insemination cycles.
Liu Y; Ye XY; Chan C
Reprod Biol Endocrinol; 2019 Jan; 17(1):14. PubMed ID: 30674305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
